Related references
Note: Only part of the references are listed.Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double-blind placebo-controlled clinical trials
Koutaro Yokote et al.
CARDIOVASCULAR DIABETOLOGY (2021)
A cohort study on risk factors of high-density lipoprotein cholesterol hypolipidemia among urban Chinese adults
Fang Tang et al.
LIPIDS IN HEALTH AND DISEASE (2021)
Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients
Jessica R. Allegretti et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
Magdy El-Salhy et al.
GUT (2020)
Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial
Laura Craven et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening
Ting Zhang et al.
PROTEIN & CELL (2020)
Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets
Hui Wang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial
Elaine W. Yu et al.
PLOS MEDICINE (2020)
Gut microbiota and cardiovascular disease: opportunities and challenges
Negin Kazemian et al.
MICROBIOME (2020)
Konjaku flour reduces obesity in mice by modulating the composition of the gut microbiota
Yongbo Kang et al.
INTERNATIONAL JOURNAL OF OBESITY (2019)
Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes?
Judith Aron-Wisnewsky et al.
CURRENT DIABETES REPORTS (2019)
Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome
Avner Leshem et al.
FRONTIERS IN IMMUNOLOGY (2019)
Fecal microbiota transplantation beyond Clostridioides difficile infections
Koen Wortelboer et al.
EBIOMEDICINE (2019)
Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome-A Systematic Review
Zhengxiao Zhang et al.
NUTRIENTS (2019)
Dietary compounds and traditional Chinese medicine ameliorate type 2 diabetes by modulating gut microbiota
Qixing Nie et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)
Long-term impact of fecal transplantation in healthy volunteers
Oleg Goloshchapov et al.
BMC MICROBIOLOGY (2019)
Gut microbiota and health: connecting actors across the metabolic system
F. Fava et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2019)
The Super-Donor Phenomenon in Fecal Microbiota Transplantation
Brooke C. Wilson et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Fecal microbiota transplantation in children does not significantly alter body mass index
Dong Xi et al.
TRANSLATIONAL PEDIATRICS (2019)
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
Mariel F. van Stee et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome
Loek P. Smits et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Benjamin H. Mullish et al.
GUT (2018)
Case series of successful treatment with fecal microbiota transplant (FMT) oral capsules mixed from multiple donors even in patients previously treated with FMT enemas for recurrent Clostridium difficile infection
Mahtab Chehri et al.
MEDICINE (2018)
Interaction between gut microbiome and cardiovascular disease
Jieting Peng et al.
LIFE SCIENCES (2018)
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition
Ruud S. Kootte et al.
CELL METABOLISM (2017)
Gut microbiome and lipid metabolism: from associations to mechanisms
Zheng Wang et al.
CURRENT OPINION IN LIPIDOLOGY (2016)
Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
Ming-liang Chen et al.
MBIO (2016)
Systematic Review: Adverse Events of Fecal Microbiota Transplantation
Sinan Wang et al.
PLOS ONE (2016)
Gut microbiome and metabolic syndrome
Mohsen Mazidi et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2016)
The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids
Jingyuan Fu et al.
CIRCULATION RESEARCH (2015)
Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in Children
Chenhong Zhang et al.
EBIOMEDICINE (2015)
Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis
Zain Kassam et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations
Judith A. Finegold et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice
Na Fei et al.
ISME JOURNAL (2013)
Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
Anne Vrieze et al.
GASTROENTEROLOGY (2012)
Share Paper
